Ron Knickerbocker

Ron Knickerbocker, Ph.D., is Senior Vice President, Biometrics and Clinical Development Strategy at Theseus Pharmaceuticals. Dr. Knickerbocker has over 25 years’ experience in the biotechnology and pharmaceutical industries. He most recently served as Vice President, Biometrics at EQRx where he built a biometrics team within a startup and was part of a Development Leadership Team that led global regulatory submissions for two oncology compounds. Prior to that Ron has led organizations, focusing primarily on oncology development, at companies including Ariad Pharmaceuticals, Anchiano Therapeutics, Genzyme, Pfizer, and Eli Lilly and Company. Ron has a Ph.D. in Statistics from Texas A&M University.